These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37315712)

  • 21. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction.
    Prentice KJ; Luu L; Allister EM; Liu Y; Jun LS; Sloop KW; Hardy AB; Wei L; Jia W; Fantus IG; Sweet DH; Sweeney G; Retnakaran R; Dai FF; Wheeler MB
    Cell Metab; 2014 Apr; 19(4):653-66. PubMed ID: 24703697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
    Ussher JR; Lopaschuk GD
    Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of renal failure on drug transport and metabolism.
    Sun H; Frassetto L; Benet LZ
    Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
    Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy.
    Guan Z; Chen J; Wang L; Hao M; Dong X; Luo T; Jiang J; Lin Z; Li X; Chen P; Yang Z; Ye X; Wang L; Xian S; Chen Z
    Phytomedicine; 2023 Jan; 108():154494. PubMed ID: 36279758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Plasma Exposures of Conjugated Metabolites of Morinidazole in Renal Failure Patients: A Critical Role of Uremic Toxins.
    Kong F; Pang X; Zhong K; Guo Z; Li X; Zhong D; Chen X
    Drug Metab Dispos; 2017 Jun; 45(6):593-603. PubMed ID: 28314825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
    Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
    Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
    Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of plasma 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease.
    Ono H; Tanaka R; Suzuki Y; Oda A; Sato H; Tatsuta R; Ando T; Shin T; Ohno K; Itoh H
    Clin Transl Sci; 2024 Feb; 17(2):e13731. PubMed ID: 38564661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate.
    Miyamoto Y; Iwao Y; Mera K; Watanabe H; Kadowaki D; Ishima Y; Chuang VT; Sato K; Otagiri M; Maruyama T
    Biochem Pharmacol; 2012 Nov; 84(9):1207-14. PubMed ID: 22898098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic Elicitation Prevents Ventricular Remodeling via Alleviations of Myocardial Mitochondrial Injury Linked to Inflammation in Ischemia-Induced Chronic Heart Failure Rats.
    Zhao Y; Sun H; Li K; Shang L; Liang X; Yang H; Dong Z; Xiaokereti J; Shang S; Zhou Q; Zhou X; Zhang L; Lu Y; Tang B
    Mediators Inflamm; 2021; 2021():4504431. PubMed ID: 34849103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
    Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
    J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.
    Chambers KT; Leone TC; Sambandam N; Kovacs A; Wagg CS; Lopaschuk GD; Finck BN; Kelly DP
    J Biol Chem; 2011 Apr; 286(13):11155-62. PubMed ID: 21321124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation.
    Gao Z; Zhang C; Peng F; Chen Q; Zhao Y; Chen L; Wang X; Chen X
    Stem Cell Res Ther; 2022 May; 13(1):191. PubMed ID: 35526054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia.
    Takamura N; Maruyama T; Otagiri M
    Clin Chem; 1997 Dec; 43(12):2274-80. PubMed ID: 9439444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malonyl CoA control of fatty acid oxidation in the ischemic heart.
    Dyck JR; Lopaschuk GD
    J Mol Cell Cardiol; 2002 Sep; 34(9):1099-109. PubMed ID: 12392882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.